RUCAPARIB CAMSYLATE vs RUXOLITINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
RUCAPARIB CAMSYLATE vs RUXOLITINIB: Safety Overview
| Metric | RUCAPARIB CAMSYLATE | RUXOLITINIB |
|---|---|---|
| Total FAERS Reports | 8,240 | 68,133 |
| Deaths Reported | 448 | 10,908 |
| Death Rate | 5.4% | 16.0% |
| Hospitalizations | 1,148 | 14,461 |
| Average Patient Age | 65.1 yrs | 59.7 yrs |
| % Female Patients | 95.2% | 48.8% |
| FDA Approval Date | Dec 19, 2016 | Nov 16, 2011 |
| Manufacturer | pharmaand GmbH | Incyte Corporation |
| Route | ORAL | TOPICAL |
| Marketing Status | Prescription | Prescription |